ACE and chronic kidney disease: ACE inhibitors or ARBs are the preferred first-line therapy for managing blood pressure in patients with diabetes, hypertension, an eGFR <60 mL/min/1.73 m2, and a UAC ≥ 30 mg/mmol, due to their established benefits in preventing the progression of chronic kidney disease (CKD) (9).